Lyndra Therapeutics
Developer of therapeutic medicine
Based in MA
🤖
AI Overview
With $450K in lobbying spend across 13 quarterly filings, Lyndra Therapeutics is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2023.
$450K
Total Spend
4
Years Active
1
Firms Hired
5
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $170K |
| 2021 | $240K |
| 2022 | $40K |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Provide strategic guidance and support to advance the utilization of, and investment in, the company's products, and advise the client on legislative and regulatory issues.
- •Provide strategic guidance and support to advance the utilization of, and investment in, the company's platform and products, and advise the client on legislative, regulatory and potential government
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.